A newly registered trial testing an immune ingredient against common cold incidence reflects a broader shift toward outcome-based, real-world trial design in supplement research. This article examines that registration alongside related work to show what a methodological trend does—and does not—tell us before results exist.
Connected intelligence
Explore the ingredient records and WQ formulas directly connected to this editorial review.
Continue the research
Latest from this journal.
Recent publications on kava, olive leaf, lavender, and turmeric reveal a shared research focus: verifying what botanical extracts actually contain through rigorous...
Read article →
A structured comparison of Andrographis paniculata research — separating in vitro, animal, and human clinical findings on immune and digestive-related outcomes —...
Read article →
A Class II FDA recall over an undeclared fish-derived collagen source sits alongside a finalized FTC advertising order and a dozen contemporaneous...
Read article →
